Literature DB >> 7627758

Progression of lens opacities in cataract patients after one year.

B V Magno1, M B Datiles, M S Lasa.   

Abstract

We used the Lens Opacities Classification System II to clinically grade the lenses of 57 patients with age-related cataracts in at least one eye. Progression or regression in each lens region was defined as a one or more step change in the Lens Opacities Classification System II grading noted at 1 year and maintained at the 1 1/2 to 2 year visit (the validation visit). A validated change in a lens region in one eye of a patient was considered a change in that region for that patient. Person-specific rates of cataract progression at 1 year were 42% for nuclear, 32% for cortical and 10% for posterior subcapsular opacities. Corresponding regression rates were 5%, 4%, and 2% for nuclear, cortical and posterior subcapsular opacities, respectively. Progression rates were significantly greater than the regression rates only for nuclear and cortical opacities (p < 0.0005). These findings show the applicability of the clinical Lens Opacities Classification System II method in documenting and monitoring lens changes over time. The usefulness of person-specific analysis was also shown.

Entities:  

Mesh:

Year:  1995        PMID: 7627758     DOI: 10.1111/j.1600-0420.1995.tb00012.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  3 in total

1.  Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements.

Authors:  J M Teikari; M Rautalahti; J Haukka; P Järvinen; A M Hartman; J Virtamo; D Albanes; O Heinonen
Journal:  J Epidemiol Community Health       Date:  1998-07       Impact factor: 3.710

2.  Five year incidence of cataract surgery: the Blue Mountains Eye Study.

Authors:  J Panchapakesan; P Mitchell; K Tumuluri; E Rochtchina; S Foran; R G Cumming
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

3.  Falls and health status in elderly women following first eye cataract surgery: an economic evaluation conducted alongside a randomised controlled trial.

Authors:  Tracey H Sach; Alexander J E Foss; Richard M Gregson; Anwar Zaman; Francis Osborn; Tahir Masud; Rowan H Harwood
Journal:  Br J Ophthalmol       Date:  2007-06-21       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.